Harvard University is facing a nearly $2 billion freeze in federal funding, according to Bloomberg. The freeze follows the university’s rejection of a deal with the Trump administration, triggering economic concerns across the state. Harvard’s defiance risks destabilizing a multibillion-dollar ecosystem of hospitals, biotech companies, and research institutions that depend on federal support. Stop-work orders have already hit NIH-backed projects, and Harvard Medical School has advised researchers to cut costs. Experts warn that the broader impact on the state's workforce and innovation sectors could be severe.
